New Deal
Michael Levy
CEO at OCTAGON CAPITAL
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (10)
Key Relationships
Sort
I-MAB
Hillhouse Capital Group
£315m
33 dealmakers
4d Molecular Therapeutics
Mirae Asset Financial Group
£56m
11 dealmakers
Arctic Vision
Loyal Valley Capital
£72m
6 dealmakers
Epimab Biotherapeutics
Octagon Investments
£86m
16 dealmakers
Century Therapeutics
Fidelity Management & Research Company
£115m
24 dealmakers
Hummingbird Bioscience
Frazier Healthcare Partners
£88m
18 dealmakers
Numab Therapeutics
Novo Holdings
£78m
Sonoma Biotherapeutics
Casdin Capital
£190m
15 dealmakers
Edge Medical Robotics
Octagon Capital
£148m
Abogen Biosciences
Invesco Asset Management
£520m
28 dealmakers